Cilnidipine is a novel slow-acting blocker of vascular L-type calcium channels that does not target protein kinase C.

MLA

Löhn, Matthias, et al. “Cilnidipine Is a Novel Slow-Acting Blocker of Vascular L-Type Calcium Channels That Does Not Target Protein Kinase C.” Journal of Hypertension, vol. 20, no. 5, May 2002, pp. 885–93. EBSCOhost, https://doi.org/10.1097/00004872-200205000-00023.

APA

Löhn, M., Muzzulini, U., Essin, K., Tsang, S.-Y., Kirsch, T., Litteral, J., Waldron, P., Conrad, H., Klugbauer, N., Hofmann, F., Haller, H., Luft, F. C., Huang, Y., & Gollasch, M. (2002). Cilnidipine is a novel slow-acting blocker of vascular L-type calcium channels that does not target protein kinase C. Journal of Hypertension, 20(5), 885–893. https://doi.org/10.1097/00004872-200205000-00023

Chicago

Löhn, Matthias, Ulf Muzzulini, Kirill Essin, Suk-Ying Tsang, Torsten Kirsch, Jennifer Litteral, Patricia Waldron, et al. 2002. “Cilnidipine Is a Novel Slow-Acting Blocker of Vascular L-Type Calcium Channels That Does Not Target Protein Kinase C.” Journal of Hypertension 20 (5): 885–93. doi:10.1097/00004872-200205000-00023.